Prepare for the Licensed Chemical Dependency Counselor (LCDC) Certification Examination with this comprehensive 2026 study guide featuring 400+ expertly verified practice questions and detailed answers covering the complete scope of addiction counseling and substance use disorder treatment. This exam preparation resource provides an in-depth review of the competencies required for LCDC certification, including DSM-5 substance use disorders, addiction pharmacology, psychopharmacology, screening and assessment, treatment planning, counseling techniques, case management, relapse prevention, ethics, multicultural counseling, group counseling, family systems, co-occurring mental health disorders, crisis intervention, recovery models, and evidence-based clinical practice. The certification-style questions are designed to strengthen clinical judgment, reinforce counseling knowledge, and improve success on licensing examinations.
This study guide closely reflects the knowledge domains assessed on LCDC certification examinations, offering extensive coverage of addiction neuroscience, the brain reward pathway, dopamine and GABA neurotransmission, pharmacokinetics, pharmacodynamics, pharmacotherapeutics, controlled substance schedules, medication-assisted treatment (MAT), agonists, antagonists, antidipsotropics, withdrawal management, detoxification protocols, relapse prevention planning, motivational interviewing, Transtheoretical Model of Change, harm reduction strategies, SMART Recovery, Alcoholics Anonymous (AA), group development stages, family therapy models, Addiction Severity Index (ASI), treatment planning, DSM-5 diagnostic criteria, screening instruments including AUDIT, CAGE, DAST, MAST, SASSI, SAPC, TWEAK, and RAPS4, ethical decision-making, confidentiality regulations, crisis management, documentation standards, SOAP notes, and integrated treatment for co-occurring disorders. The structured question-and-answer format makes this resource ideal for self-assessment, classroom revision, continuing education, and final licensing examination preparation.
The content is aligned with nationally recognized addiction counseling competencies and incorporates evidence-based recommendations from the Substance Abuse and Mental Health Services Administration (SAMHSA), the American Society of Addiction Medicine (ASAM), the American Psychiatric Association (DSM-5-TR), the National Association for Alcoholism and Drug Abuse Counselors (NAADAC), and the American Society of Addiction Medicine (ASAM) Criteria for treatment placement. Core concepts reflect current best practices in substance use disorder assessment, motivational enhancement, recovery-oriented systems of care, integrated treatment, behavioral therapies, medication-assisted treatment, trauma-informed care, relapse prevention, and ethical counseling practice. Whether preparing for the LCDC licensing examination, addiction counseling coursework, or professional practice in behavioral health, this guide provides a comprehensive review of the knowledge and clinical skills expected of licensed chemical dependency counselors.
Relevant for Students:
Licensed Chemical Dependency Counselor (LCDC) certification candidates
Addiction Counseling students
Substance Abuse Counseling students
Alcohol and Drug Counselor trainees
Certified Alcohol and Drug Counselor (CADC) candidates
Certified Addiction Counselor (CAC) candidates
Behavioral Health students
Mental Health Counseling students
Psychology students
Social Work (BSW/MSW) students
Human Services students
Marriage and Family Therapy students
Substance Use Disorder (SUD) treatment professionals
Behavioral Health clinicians preparing for licensure or certification
References:
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). American Psychiatric Publishing.
Substance Abuse and Mental Health Services Administration. (2020). Treatment Improvement Protocol (TIP) 35: Enhancing Motivation for Change in Substance Use Disorder Treatment. U.S. Department of Health and Human Services.
Substance Abuse and Mental Health Services Administration. (2020). Treatment Improvement Protocol (TIP) 42: Substance Use Disorder Treatment for Persons With Co-Occurring Disorders. U.S. Department of Health and Human Services.
American Society of Addiction Medicine. (2023). The ASAM Criteria®: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions (4th ed.).
Miller, W. R., & Rollnick, S. (2023). Motivational Interviewing: Helping People Change (4th ed.). Guilford Press.
Beck, J. S. (2021). Cognitive Behavior Therapy: Basics and Beyond (3rd ed.). Guilford Press.
NAADAC, The Association for Addiction Professionals. NAADAC Code of Ethics.
Keywords:
LCDC, Licensed Chemical Dependency Counselor, LCDC certification, LCDC exam, addiction counseling, substance abuse counseling, substance use disorder, addiction treatment, DSM-5, DSM-5-TR, addiction pharmacology, psychopharmacology, brain reward pathway, dopamine, GABA, treatment planning, relapse prevention, motivational interviewing, stages of change, SMART Recovery, Alcoholics Anonymous, AA, group counseling, family therapy, case management, crisis intervention, screening, assessment, AUDIT, CAGE, DAST, MAST, SASSI, SAPC, TWEAK, RAPS4, Addiction Severity Index, ASI, SOAP notes, confidentiality, ethics, co-occurring disorders, medication assisted treatment, MAT, behavioral health, CADC, CAC, evidence based practice
Content preview
LCDC Exam Keely 2026 Exam
Questions and Correct
Answers | New Update
Entheogens - ANSWER ✔✔Shamanic drugs used during shamanic
or spiritual rituals and as tools for studying the mind
Psychoactive substance disorder - ANSWER ✔✔a pattern of
substance use led to problems, damage, distress 12 months
substance abuse disorder - ANSWER ✔✔abusing drug, medication
side effect, exposure to a toxin.
Substance intoxication or withdrawal - ANSWER ✔✔Behavorial,
Psychological, Physiological symptoms due to effects of the substance.
,Could cause substance induced delirium, dementia, psychosis, mood
disorder, anxiety disorder, sexual dysfunction or sleep dysfunction
Treatment options substance abuse disorder - ANSWER
✔✔outpatient or inpatient; residential or day care; group, individual or
family counseling; methadone maintenance, detoxification and self help
groups
DSM criteria substance abuse disorder - ANSWER ✔✔11 symptoms
2 or more occured at a time in the past 12 months
tolerance
withdrawal
an increase in the amount of the drug taken
an inability to control usage
a large amount of time obtaining the drug
giving up important activities to use drugs
continued use regardless of the ill effects
craving
recurrent drug use leads to inabilty to maintain job
recurrent drug use though it is physically harmful
,recurrent drugs despite social problems
Pharmacology - ANSWER ✔✔chemistry effects and uses of drugs
pharmacoepidemiology - ANSWER ✔✔the use and effect of drugs in
socieities
pharmacognosy - ANSWER ✔✔drugs obtained from natural sources
plants, mold
pharmacokinetics - ANSWER ✔✔what the body does with the drugs
pharmacodynamics - ANSWER ✔✔what drugs do to the body
pharmacotherapeutics - ANSWER ✔✔the use of drugs to treat
disease.
Who was John Jacob Abel - ANSWER ✔✔A researcher and the first
US pharmacology professor. He pursured early endocrine research. The
first to isolate adrenaline (epinephrine) and he crystallized insulin in
1926.
Psychopharmacology - ANSWER ✔✔the scientific study of the
effects of drugs on both normal and abnormal mental functions, moods,
senation, thinking and behaviors.
COPYRIGHT©PROFFKERRYMARTIN 2025/2026. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
PRIVACY STATEMENT. ALL RIGHTS RESERVED
, Acetylocholine - ANSWER ✔✔A major neurotransmitte responsible
for the transmission of nerve impulses in the body, including those
responsible for muscle movement.
Agonist/Antagonist - ANSWER ✔✔Counteracts or inhibits
neurotransmitter effects on the post-synaptic cells
Akathisia - ANSWER ✔✔Restlessness-from mild anxiety to difficulty
lying or sitting still, to insomina; often an extrapyramidal side effects
produced by neuroleptic drugs
Anticholinergic - ANSWER ✔✔Acetylcholine blocker in CNS and PNS
Antiemetic - ANSWER ✔✔Aids in the prevention of nausea and
vomiting
Arrhythmia - ANSWER ✔✔Atypical heart rhythm
Arthralgia - ANSWER ✔✔Joint Pain
Ataxia - ANSWER ✔✔Loss of muscle coordination, especially
voluntary muscles
Athetosis - ANSWER ✔✔continuous sinuously writing movements
Augmenter (add-on) meds - ANSWER ✔✔Medications prescribed to
increase the efficacy of a primary medication